Browse > Article

Improving Diagnostic Accuracy for Malignant Nodes and N Staging in Non-Small Cell Lung Cancer Using CT-Corrected FDG-PET  

Lee, Eun-Jeong (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Choi, Joon-Young (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Lee, Kyung-Soo (Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Chung, Hyun-Woo (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Lee, Su-Jin (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Cho, Young-Seok (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Choi, Yong (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Choe, Yearn-Seong (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Lee, Kyung-Han (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Kwon, O-Jung (Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Shim, Young-Mog (Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Kim, Byung-Tae (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Publication Information
The Korean Journal of Nuclear Medicine / v.39, no.4, 2005 , pp. 231-238 More about this Journal
Abstract
Purpose: We investigated prospectively whether the interpretation considering the patterns of FDG uptake and the findings of unenhanced CT for attenuation correction can improve the diagnostic accuracy for assessing malignant lymph node (LN) and N stage in non-small cell lung cancor (NSCLC) using CT-corrected FDG-PET (PET/CT). Materials & Methods: Subjects were 91 NSCLC patients (M/F 62/29, age: $60{\pm}9$ yr) who underwent PET/CT before in dissection. We evaluated the maximum SUV (maxSUV), patterns of FDG uptake, short axis diameter, and calcification of LN showing abnormally increased FDG uptake. Then we investigated criteria improving the diagnostic accuracy and correlated results with postoperative pathology. In step 1, in was classified as benign or malignant based on maxSUV only. In step 2, LN was regarded as benign if it had lower maxSUV than the cut-off value of step 1 or it had calcification irrespective of its maxSUV. In step 3, LN regarded as malignant in step 2 was classified as benign if they had indiscrete margin of FDG uptake. Results: Among 432 LN groups surgically resected (28 malignant, 404 benign), 71 showed abnormally increased FDG uptake. We determined the cut-off as maxSUV=3.5 using ROC curve analysis. The sensitivity, specificity, and accuracy for assessing malignant LN were 64.3%, 86.9%, 85.4% in step 1, 64.3%, 95.0%, 93.1% in step 2, and 57.1%, 98.0%, 95.4% in step3, respectively. The accuracy for assessing N stage was 64.8% in step 1, 80.2% in step 2, and 85.7% in step 3. Conclusion: interpreting PET/CT, consideration of calcification and shape of the FDG uptake margin along with maxSUV can improve the diagnostic accuracy for assessing malignant involvement and N stage of hilar and mediastinal LNs in NSCLC.
Keywords
FDG; PET/CT; Lung; Carcinoma;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Pieterman RM, van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koeter GH, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000;343:254-61   DOI   ScienceOn
2 Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Bogaert J, Maes A, et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998;16:2142-49   DOI   PUBMED
3 Chin R, Jr., Ward R, Keyes JW, Choplin RH, Reed JC, Wallenhaupt S, et al. Mediastinal staging of non-small-cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 1995;152:2090-96   DOI   PUBMED   ScienceOn
4 Choi JY, Lee KH, Shim YM, Lee KS, Kim JJ, Kim SE, et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med 2000;41:808-15
5 Takamochi K, Nagai K, Yoshida J, Suzuki K, Ohde Y, Nishimura M, et al. The role of computed tomographic scanning in diagnosing mediastinal node involvement in non-small cell lung cancer. J Thorac Cardiovasc Surg 2000;119:1135-40   DOI   ScienceOn
6 Gawne-Cain ML, Hansell DM. The pattern and distribution of calcified mediastinal lymph nodes in sarcoidosis and tuberculosis: a CT study. Clin Radiol 1996;51:263-67   DOI   ScienceOn
7 Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-23   DOI   ScienceOn
8 Libshitz HI, McKenna RJ, Jr., Haynie TP, McMurtrey MJ, Mountain CT. Mediastinal evaluation in lung cancer. Radiology 1984;151:295-99   DOI   PUBMED
9 Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123:137S-46S   DOI   ScienceOn
10 Libshitz HI, McKenna RJ, Jr. Mediastinal lymph node size in lung cancer. AJR Am J Roentgenol 1984;143:715-18   DOI   PUBMED   ScienceOn
11 Gupta NC, Tamim WJ, Graeber GG, Bishop HA, Hobbs GR. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. 2001;120:521-27   DOI   ScienceOn
12 Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, et al. Non-small cell lung cancer: dual-modality PETICT in preoperative staging. Radiology 2003;229:526-33   DOI   ScienceOn
13 Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191 :371-77   DOI   PUBMED
14 Weng E, Tran L, Rege S, Safa A, Sadeghi A, Juillard G, et al. Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer. Am J Clin Oncol 2000;23:47-5
15 Yoon YC, Lee KS, Shim YM, Kim BT, Kim K, Kim TS. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology 2003;227:764-70   DOI   ScienceOn
16 Moon WK, Im JG, Yeon KM, Han MC. Mediastinal tuberculous lymphadenitis: CT fmdings of active and inactive disease. AJR Am J Roentgenol 1998;170:715-18   DOI   PUBMED   ScienceOn
17 Ratto GB, Mereu C, Motta G. The prognostic significance of preoperative assessment of mediastinal lymph nodes in patients with lung cancer. Chest 1988;93:807-13   DOI   ScienceOn
18 Pearson FG, DeLarue NC, lives R, Todd TR, Cooper JD. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorae Cardiovase Surg 1982;83:1-11
19 Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500-07   DOI   ScienceOn
20 Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE, et al. Staging non-small cell lung cancer with whole-body PET. Radiology 1999;212:803-09   DOI   PUBMED
21 Inoue T, Kim EE, Komaki R, Wong FC, Bassa P, Wong WH, et al. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995;36:788-93   PUBMED
22 Gross BH, Glazer GM, Orringer MB, Spizarny DL, Flint A. Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance. Radiology 1988;166:71-74   DOI   PUBMED
23 Steinert HC, Hauser M, Allemann F, Engel H, Berthold T, von Schulthess GK, et aI. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997;202:441-46   DOI   PUBMED
24 Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT. Radiology 1999;213 :530-36   DOI   PUBMED
25 Verhagen AF, Bootsma GP, Tjan-Heijnen VC, van der Wilt GJ, Cox AL, Brouwer MH, et al. FDG-PET in staging lung cancer: how does it change the algorithm? Lung Cancer 2004;44:175-81   DOI   ScienceOn